BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34125346)

  • 1. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
    Postlewait LM; Teshome M; Adesoye T; DeSnyder SM; Lim B; Kuerer HM; Bedrosian I; Sun SX; Woodward WA; Le-Petross HT; Valero V; Ueno NT; Lucci A
    Ann Surg Oncol; 2021 Dec; 28(13):8610-8621. PubMed ID: 34125346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral axillary nodal involvement from invasive breast cancer.
    Kiluk JV; Prowler V; Lee MC; Khakpour N; Laronga C; Cox CE
    Breast; 2014 Jun; 23(3):291-4. PubMed ID: 24709584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying factors that impact survival among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer.
    Grova MM; Strassle PD; Navajas EE; Gallagher KK; Ollila DW; Downs-Canner SM; Spanheimer PM
    Ann Surg Oncol; 2021 Apr; 28(4):2182-2190. PubMed ID: 32974693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
    Niikura N; Liu J; Costelloe CM; Palla SL; Madewell JE; Hayashi N; Yu TK; Tokuda Y; Theriault RL; Hortobagyi GN; Ueno NT
    Oncologist; 2011; 16(6):772-82. PubMed ID: 21632453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Chkheidze R; Sanders MAG; Haley B; Leitch AM; Sahoo S
    Clin Breast Cancer; 2018 Aug; 18(4):298-304. PubMed ID: 29233470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
    Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
    Postlewait LM; Teshome M; DeSnyder SM; Lim B; Kuerer HM; Bedrosian I; Woodward WA; Ueno NT; Lucci A
    Ann Surg Oncol; 2020 Nov; 27(12):4603-4612. PubMed ID: 32710271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
    van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
    Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
    Partain N; Postlewait LM; Teshome M; Rosso K; Hall C; Song J; Meas S; DeSnyder SM; Lim B; Valero V; Woodward W; Ueno NT; Kuerer H; Lucci A
    Ann Surg Oncol; 2021 Aug; 28(8):4265-4274. PubMed ID: 33403525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
    Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
    Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options for contralateral axillary lymph node metastasis in breast cancer.
    Zhang Z; Zhang Y; Sun X
    Curr Probl Cancer; 2021 Oct; 45(5):100706. PubMed ID: 33468335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
    Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
    Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.
    Fayanju OM; Ren Y; Greenup RA; Plichta JK; Rosenberger LH; Force J; Suneja G; Devi GR; King TA; Nakhlis F; Hyslop T; Hwang ES
    Breast Cancer Res Treat; 2020 Feb; 180(1):207-217. PubMed ID: 31960171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
    Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
    Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?
    Magnoni F; Colleoni M; Mattar D; Corso G; Bagnardi V; Frassoni S; Santomauro G; Jereczek-Fossa BA; Veronesi P; Galimberti V; Sacchini V; Intra M
    Ann Surg Oncol; 2020 Oct; 27(11):4488-4499. PubMed ID: 32436193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
    Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Breast Cancer at the Extremes of Age.
    Adesoye T; Babayemi O; Postlewait LM; DeSnyder SM; Sun SX; Woodward WA; Ueno NT; Hunt KK; Lucci A; Teshome M
    Ann Surg Oncol; 2021 Oct; 28(10):5626-5634. PubMed ID: 34292426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.